Enveric Biosciences Files 8-K
Ticker: ENVB · Form: 8-K · Filed: Aug 22, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Aug 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Enveric Bio filed an 8-K, check for financial updates and disclosures.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on August 22, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC, is incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This filing indicates Enveric Biosciences is providing updates on its financial status and potentially other material information to the public, which is crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports material events or financial updates without inherently indicating high risk.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- AMERI Holdings, Inc. (company) — Former company name
- SPATIALIZER AUDIO LABORATORIES INC (company) — Former company name
- August 22, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Naples, FL (location) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of this disclosure are not provided in the provided text snippet.
What financial statements and exhibits are included in this filing?
The filing states that Financial Statements and Exhibits are included, but the content of these documents is not detailed in the provided text.
When was Enveric Biosciences, Inc. previously known by other names?
The company was formerly known as AMERI Holdings, Inc. (name change effective May 27, 2015) and SPATIALIZER AUDIO LABORATORIES INC (name change effective March 23, 1995).
Where are Enveric Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the Commission File Number for Enveric Biosciences, Inc.?
The Commission File Number for Enveric Biosciences, Inc. is 001-38286.
Filing Stats: 599 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-08-22 08:00:16
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 774KB
- ex99-1_002.jpg (GRAPHIC) — 636KB
- ex99-1_003.jpg (GRAPHIC) — 843KB
- ex99-1_004.jpg (GRAPHIC) — 522KB
- ex99-1_005.jpg (GRAPHIC) — 547KB
- ex99-1_006.jpg (GRAPHIC) — 576KB
- ex99-1_007.jpg (GRAPHIC) — 385KB
- ex99-1_008.jpg (GRAPHIC) — 261KB
- ex99-1_009.jpg (GRAPHIC) — 406KB
- ex99-1_010.jpg (GRAPHIC) — 566KB
- ex99-1_011.jpg (GRAPHIC) — 676KB
- ex99-1_012.jpg (GRAPHIC) — 493KB
- ex99-1_013.jpg (GRAPHIC) — 428KB
- ex99-1_014.jpg (GRAPHIC) — 605KB
- ex99-1_015.jpg (GRAPHIC) — 473KB
- 0001493152-24-033501.txt ( ) — 11505KB
- envb-20240822.xsd (EX-101.SCH) — 3KB
- envb-20240822_lab.xml (EX-101.LAB) — 33KB
- envb-20240822_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 22, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer